enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment

Go back to enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
(NASDAQ: NVNO) Delayed: 10.60 -0.03 (0.28%)
Previous Close $10.63    52 Week High
Open $10.60    52 Week Low
Day High $10.60    P/E N/A 
Day Low $10.60    EPS
Volume 2,338